2-(2,6-dibutylphenyl)-4,5-dihydro-4,4-dimethyl-1,3-oxazole | 115890-88-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2,6-dibutylphenyl)-4,5-dihydro-4,4-dimethyl-1,3-oxazole
• 英文别名: 2-(2,6-di-n-butylphenyl)-4,4-dimethyl-2-oxazoline；2-(2,6-dibutylphenyl)-4,4-dimethyl-5H-1,3-oxazole
• CAS: 115890-88-5
• 化学式: C₁₉H₂₉NO
• 分子量: 287.445
• InChiKey: FZSOWQFXSNFVDG-UHFFFAOYSA-N

物化性质

• 沸点：
  396.8±31.0 °C(predicted)
• 密度：
  0.97±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  21
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.63
• 拓扑面积：
  21.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(2,6-dibutylphenyl)-4,5-dihydro-4,4-dimethyl-1,3-oxazole 在 N-氯代丁二酰亚胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 2,6-Dibutylbenzaldehyde
  参考文献：
  名称：

  Synthesis of 2,6-disubstituted benzylamine derivatives as reversible selective inhibitors of copper amine oxidases

  摘要：

  In order to obtain substrate-like inhibitors of copper amine oxidases (CAOs), a class of enzymes involved in important cellular processes as well as in crosslinking of elastin and collagen and removal of biogenic primary amines, we synthesized a set of benzylamine derivatives properly substituted at positions 2 and 6 and studied their biological activity towards some members of CAOs.With benzylamines 6, 7, 8 containing linear alkoxy groups we obtained reversible inhibitors of benzylamine oxidase (BAO), very active and selective toward diamine oxidase (DAO), lysyl oxidase (LO) and monoamine oxidase B (MAO B) characterized by a certain toxicity consequent to the crossing of the brain barrier. Poorly toxic, up to very active, reversible inhibitors of BAO, very selective toward DAO, LO and MAO B, were obtained with benzylamines 10, 11, 12 containing hydrophilic x-hydroxyalkoxy groups. With benzylamines 13, 14, 15, containing linear alkyl groups endowed with steric, but not conjugative effects for the absence of properly positioned oxygen atoms, we synthesized moderately active inhibitors of BAO reversible and selective toward DAO, LO and MAO B.The cross examination of the entire biological data brought us to the conclusion that the bioactive synthesized compounds most likely exert their physiological role of reversible inhibitors in consequence of the formation of a plurality of hydrogen bonds or hydrophobic non-covalent interactions with proper sites in the protein. Accordingly, the reported inhibitors may be considered as a set of research tools for general biological studies and the formation of enzyme complexes useful for X-ray structure determinations aimed at the design of more sophisticated inhibitors to always better modulate the protein activity without important side effects. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2014.01.037
• 作为产物：
  描述：

  2-(5-chloro-2-methoxyphenyl)-4,4-dimethyl-2-oxazoline 在 乙醇 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 反应 49.17h， 生成 2-(2,6-dibutylphenyl)-4,5-dihydro-4,4-dimethyl-1,3-oxazole
  参考文献：
  名称：

  1,2,3-三取代苯的恶唑啉-苄路线。将有机锂、有机铜酸盐和 α-锂腈串联添加到苄基中

  摘要：

  Le ([dimethyl-4,4 oxazoline-2yl-2]-3)benzyne generice par lithiation de la (chloro-2' phenyl-2 二甲基-4,4) oxazoline-2, permet d'acceder a des衍生多取代基苯含量不同

  DOI：

  10.1021/ja00229a037

文献信息

• Palladium-mediated ortho-alkylation of 2-aryloxazolines
  作者：J.C. Clinet、G. Balavoine

  DOI：10.1016/0022-328x(91)86285-x

  日期：1991.3

  The regioselective ortho-alkylation of 2-aryloxazolines through the reaction of their cyclopalladated complexes with 1-iodoalkanes is described. Depending upon the experimental conditions, either 2- or 2,6-substituted derivatives can be selectively prepared.

  描述了2-芳基恶唑啉通过其环钯配合物与1-碘代烷烃的区域选择性邻烷基化。根据实验条件，可以选择性地制备2-或2,6-取代的衍生物。
• PANSEGRAU, PAUL D.;RIEKER, WILLIAM F.;MEYERS, A. I., J. AMER. CHEM. SOC., 110,(1988) N 21, C. 7178-7184
  作者：PANSEGRAU, PAUL D.、RIEKER, WILLIAM F.、MEYERS, A. I.

  DOI：——

  日期：——